Antibiotics - Trimethoprim and sulfonamides: Nursing pharmacology

00:00 / 00:00

Notes

TRIMETHOPRIM AND SULFONAMIDES
DRUG NAME
silver sulfadiazine (Silvadene); sulfadiazine
trimethoprim-sulfamethoxazole (Bactrim)
*High Risk Medication 
(pediatric / geriatric)*
CLASS
Antibiotics: Sulfonamides
MECHANISM OF ACTION
  • Inhibit dihydropteroate synthetase → block folate synthesis → bacteriostatic
  • Sulfamethoxazole: inhibits dihydropteroate synthetase → blocks folate synthesis → bacteriostatic
  • Trimethoprim: inhibits dihydrofolate reductase → blocks folate synthesis → bacteriostatic
  • Combination: bactericidal
INDICATIONS
  • Silver sulfadiazine: prevention and treatment of wound sepsis in patients with second- and third-degree burns
  • Sulfadiazine: Toxoplasma gondii
  • Urinary tract infection
  • Acute otitis media
  • Traveler’s diarrhea
  • Shigellosis
  • Pneumocystis jirovecii pneumonia
  • Methicillin-resistant Staphylococcus aureus (MRSA) infection
ROUTE(S) OF ADMINISTRATION
  • Silver sulfadiazine: TOP
  • Sulfadiazine: PO
  • PO
  • IV (serious infections / Pneumocystis jirovecii pneumonia)
SIDE EFFECTS
  • Agranulocytosis
  • Skin necrosis, erythema multiforme, skin discoloration, burning sensation, rashes, and interstitial nephritis
  • CNS: headache, insomnia, anxiety, seizures, aseptic meningitis
  • CV: allergic myocarditis
  • EENT: tinnitus
  • GI: nausea, vomiting, abdominal pain, diarrhea, enterocolitis, Clostridioides difficile infection (CDI), pseudomembranous colitis, hepatotoxicity
  • GU: hyperkalemia, hyponatremia, hypoglycemia, and crystalluria
  • HEMA: anemia, thrombocytopenia, agranulocytosis, eosinophilia
  • INTEG: skin rash, Stevens-Johnson syndrome, toxic epidermal necrolysis, erythema multiforme
  • SYST: anaphylaxis, drug-induced lupus
CONTRAINDICATIONS AND CAUTIONS
  • Pregnancy, breastfeeding
  • Infants younger than two months
  • Hepatic or renal disease
  • Pregnancy, breastfeeding
  • Infants younger than two months
  • Elderly clients
  • Megaloblastic anemia, CCr <15 mL/min
  • G6PD deficiency
  • Asthma
  • Hypothyroidism

Drug interactions
  • Increase: thrombocytopenia—thiazide diuretics
  • Increase: hypoglycemic response—sulfonylurea agents
  • Increase: bone marrow depressant effects—methotrexate
  • Decrease: hepatic clearance of phenytoin, warfarin

NURSING CONSIDERATIONS: TRIMETHOPRIM AND SULFONAMIDES
DRUG NAME
trimethoprim-sulfamethoxazole for UTI
ASSESSMENT AND MONITORING
Assessment
  • Vital signs; note presence of fever
  • Symptoms: urinary urgency, burning or painful urination; pelvic or abdominal pain
  • Laboratory test results: CBC, renal and liver function tests, electrolytes, urinalysis, urine culture and sensitivity
  • Confirm a negative pregnancy test

Monitoring
  • Development of side effects
  • Therapeutic effect of a urinalysis clear of infection, absence of UTI symptoms
CLIENT EDUCATION
  • Purpose of medication: treat UTI
  • Take twice daily with a full glass of water
  • Complete the entire course of medication
  • Use an effective birth control method during therapy
  • Side effects
    • Crystalluria: stay well hydrated
    • Photosensitivity: avoid prolonged exposure to sunlight; use sunscreen, wear protective clothing when in the sun
    • Report
      • Symptoms of CDI: abdominal cramping, diarrhea, or bloody stool
      • Symptoms of Stevens-Johnson syndrome or other skin reaction: unusual rash, blistering, peeling skin
      • Symptoms of hemolytic anemia: fatigue, dark urine, or yellow skin or eyes
  • Prevent future UTIs: increase fluid intake, empty their bladder regularly and after intercourse; wipe perineal area from front to back afterward emptying their bladder

Transcript

Watch video only

Trimethoprim and sulfonamides are antibiotics that are typically administered in combination as trimethoprim-sulfamethoxazole, or TMP-SMX for short.

TMP-SMX is most commonly used to treat acute and simple urinary tract infections or UTIs, acute otitis media, traveler's diarrhea, and shigellosis. But it’s also effective in treating pneumonia and sinus infections caused by Streptococcus pneumoniae and Haemophilus influenzae.

It’s the first line therapy for the treatment and prevention of Pneumocystis jirovecii infections, which are caused by a yeast-like fungus that can affect immunocompromised people. Finally, it’s effective against Methicillin-Resistant Staphylococcus aureus, or MRSA.

Trimethoprim-sulfamethoxazole is most often given orally, and for serious infections and Pneumocystis jirovecii pneumonia, it can be administered intravenously.

Now, sulfonamides can also be used alone as sulfadiazine orally to treat infection by Toxoplasma gondii, or as silver sulfadiazine, which is administered topically in clients with second and third-degree burns to help prevent and treat wound sepsis.

Now, once administered, these medications act to inhibit the synthesis of folate, also known as folic acid or vitamin B9, which is necessary for the synthesis of DNA and RNA. As a result, they interfere with bacterial DNA and RNA synthesis, which ultimately kills the bacteria.

Elsevier

Copyright © 2024 Elsevier, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies.

Cookies are used by this site.

USMLE® is a joint program of the Federation of State Medical Boards (FSMB) and the National Board of Medical Examiners (NBME). COMLEX-USA® is a registered trademark of The National Board of Osteopathic Medical Examiners, Inc. NCLEX-RN® is a registered trademark of the National Council of State Boards of Nursing, Inc. Test names and other trademarks are the property of the respective trademark holders. None of the trademark holders are endorsed by nor affiliated with Osmosis or this website.

RELX